{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:43:51Z","timestamp":1771623831746,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.rmcr.2025.102356","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:49:44Z","timestamp":1767372584000},"page":"102356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["New therapies, new challenges: Cystic lung disease after cancer immunotherapy"],"prefix":"10.1016","volume":"59","author":[{"given":"Ananya","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Summer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-0208","authenticated-orcid":false,"given":"Michael","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmcr.2025.102356_bib1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102356_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte","year":"2022","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.rmcr.2025.102356_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1510\/icvts.2011.273201","article-title":"Pneumothorax associated with treatment for pulmonary malignancy","volume":"13","author":"Maniwa","year":"2011","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"7","key":"10.1016\/j.rmcr.2025.102356_bib4","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00432-022-03932-3","article-title":"Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world","volume":"148","author":"Kaku","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5 Suppl","key":"10.1016\/j.rmcr.2025.102356_bib5","article-title":"Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer","volume":"143","author":"Ost","year":"2013","journal-title":"3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest"},{"key":"10.1016\/j.rmcr.2025.102356_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1145986","article-title":"Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity","volume":"13","author":"Staropoli","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102356_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000502","article-title":"Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer","volume":"8","author":"Parisi","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.rmcr.2025.102356_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jjco\/hyq195","article-title":"Pneumothorax after bevacizumab-containing chemotherapy: a case report","volume":"41","author":"Yang","year":"2011","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.rmcr.2025.102356_bib9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/10781552231178461","article-title":"Combined use of pembrolizumab and lenvatinib: a review","volume":"29","author":"Eisinger","year":"2023","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"4","key":"10.1016\/j.rmcr.2025.102356_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0035-1556064","article-title":"Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation","volume":"36","author":"Marchetti","year":"2015","journal-title":"Semin. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:16:08Z","timestamp":1770293768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007125001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"alternative-id":["S2213007125001923"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102356","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapies, new challenges: Cystic lung disease after cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102356"}}